Diabetes and Metabolism Updates From ASN 2023 Diabetes and Metabolism Updates From ASN 2023

Highlights in diabetes and metabolism from ASN 2023 include the AYAME trial, examining bardoxolone methyl in diabetic kidney disease, as well as a novel aldosterone synthase inhibitor and zibotentan.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Nephrology ReCAP Source Type: news